Interagency Communication On Trial Designs Urged At FDA/NIH Meeting

FDA and National Institutes of Health staff should compare notes earlier to ensure that research conducted under the NIH umbrella also meets the needs of FDA regulators, speakers said at a June 2 public meeting sponsored by the agencies